Titlebook: Surgical Oncology Manual; Frances C. Wright,Jaime Escallon,Usmaan Hameed Book 20162nd edition University of Toronto General Surgery Oncolo

潔凈

Creditee

Institution

Anal Cancer,th 5-year disease-free survival of around 50–68 %. Surgery has a considerable role as a salvage treatment option with R0 resections in up to 90 % of patients. For patients with metastatic disease chemotherapy should be the standard treatment.

不發(fā)音

Hepatocellular Carcinoma,nd/or multifocal disease. Other treatment options such as radiofrequency ablation, transarterial chemoembolization, sorafenib, and stereotactic body radiation may also be applied and are very useful in several clinical scenarios. In this chapter we resume what is the current state of the art for the management of HCC.

避開(kāi)

一加就噴出

FLIRT

Ampullary Cancer, use of adjuvant therapies due to the relative rarity of this histologic subtype. Recommendations for adjuvant therapy are largely extrapolated from studies for other pancreaticobiliary malignancies. Multidisciplinary management in experienced centres is advised for these rare and complex tumors.

FEAT

充氣女

相反放置

Non-melanoma Skin Cancer,rs as they have a higher metastatic potential (~5 % at 5 years). There are a variety of treatment options for both BCC and SCC including surgical excision, topical therapy, local destructive techniques, and radiation therapy.